BlackRock’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.01M Buy
2,054,316
+29,372
+1% +$76.1K ﹤0.01% 3915
2025
Q4
$3.62M Buy
2,024,944
+209,014
+12% +$458K ﹤0.01% 3948
2025
Q3
$3.3M Sell
1,815,930
-1,066,179
-37% -$1.72M ﹤0.01% 3943
2025
Q2
$2.11M Sell
2,882,109
-3,472,424
-55% -$2.63M ﹤0.01% 4044
2025
Q1
$6.35M Sell
6,354,533
-752,463
-11% -$1.29M ﹤0.01% 3539
2024
Q4
$75.3M Buy
7,106,996
+920,102
+15% +$11M ﹤0.01% 2232
2024
Q3
$81.7M Buy
6,186,894
+1,583,500
+34% +$18.5M ﹤0.01% 2198
2024
Q2
$45.3M Buy
4,603,394
+3,617,823
+367% +$37.4M ﹤0.01% 2472
2024
Q1
$13.6M Sell
985,571
-58,433
-6% -$945K ﹤0.01% 3188
2023
Q4
$17.8M Buy
1,044,004
+1,019,004
+4,076% +$12.5M ﹤0.01% 3078
2023
Q3
$353K Buy
+25,000
New +$312K ﹤0.01% 4520

Other funds holding NMRA